The Cancer Prevention and Control Program (CPC) represents a realignment of the former two population sciences programs (Cancer Control and Carcinogenesis, Biomarkers and Epidemiology). As the nexus for population science-focused research at Lombardi, the mission of CPC is to conduct population sciences research across the translational spectrum from discovery to interventions to policy. To accomplish this mission, we conduct research around four distinct themes and one cross-cutting theme. Theme 1 - Liver and Bladder Cancer focuses on investigation of environmental, genetic, and behavioral risks and biomarkers associated with liver and bladder cancer occurrence and early detection. Theme 2 - Translational Genomics focuses on investigations of cancer genetic/genomic risk testing to inform prevention, improve patient outcomes, and develop interventions to enhance clinical and policy translation. Theme 3 - Treatment and Survivorship focuses on cancer treatment and survivorship outcomes and the development of interventions to improve these outcomes. Theme 4 - Modeling focuses on population risk prediction and the impact of cancer control interventions to inform clinical practice and policy debates about the most effective and cost-effective care. In addition to these distinct themes. Cancer Disparities is a cross-cutting theme that is integrated within each ofthe four distinct programmatic foci. The program has 24 members, led by Marc Schwartz, PhD, and Christopher Loffredo, PhD, and includes faculty from 7 Departments and 2 institutions. Total direct funding is $11M in the last budget year, of which $6.7M is from the NCI (direct costs). Program members published 357 peer-reviewed publications during the current funding period of which 34% were intraprogrammatic, 22% were interprogrammatic and 63% involved external collaborators. Program members used all but one of the Shared Resources. The CPC addresses the cancer control needs of our catchment area through a strong research program focused on lifestyle, cancer-related behaviors, and health system factors. Research in the catchment area is facilitated through two community-based research sites: the Capital Breast Care Center and a new community-based center for disparities research and outreach located in Southeast DC. In addition to support of these community-based sites, Lombardi has added value to CPC through the recruitment and support of 12 new faculty members, investment in infrastructure, including laboratories, and support for biostatistics and bioinformatics.

Public Health Relevance

The goal of CPC is to translate population science 'discoveries' into developing and testing interventions, applying effective interventions to the clinic and populations, and assessing policy and practice implications. To accomplish this goal, the program conducts research around four distinct thematic areas (Liver and Bladder Cancer Research, Translational Genomics Research, Treatment and Survivorship Research, and Modeling Research), with cancer disparities as an integrated cross-cutting theme.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-25
Application #
9483616
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
25
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Shiao-Pieng; Kao, Chen-Yu; Chang, Shun-Cheng et al. (2018) Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. PLoS One 13:e0192632
Paffhausen, Emily S; Alowais, Yasir; Chao, Cara W et al. (2018) Discovery of a stem-like multipotent cell fate. Am J Stem Cells 7:25-37
Akinyemiju, Tomi F; Demb, Joshua; Izano, Monika A et al. (2018) The association of early life socioeconomic position on breast cancer incidence and mortality: a systematic review. Int J Public Health 63:787-797
Tiek, D M; Rone, J D; Graham, G T et al. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Sci Rep 8:7222
Furth, Priscilla A (2018) Peroxisome proliferator-activated receptor gamma and BRCA1. Endocr Relat Cancer :
Sehrawat, Archana; Gao, Lina; Wang, Yuliang et al. (2018) LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A 115:E4179-E4188
Gusev, Yuriy; Bhuvaneshwar, Krithika; Song, Lei et al. (2018) The REMBRANDT study, a large collection of genomic data from brain cancer patients. Sci Data 5:180158
Oppong, Bridget A; Dash, Chiranjeev; O'Neill, Suzanne et al. (2018) Breast density in multiethnic women presenting for screening mammography. Breast J 24:334-338
Fernandez, Harvey R; Gadre, Shreyas M; Tan, Mingjun et al. (2018) The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer. Cell Death Differ 25:1239-1258
Schmidt, Marcel Oliver; Garman, Khalid Ammar; Lee, Yong Gu et al. (2018) The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation. J Invest Dermatol 138:179-188

Showing the most recent 10 out of 1120 publications